ArticleGenes & diseases2024

Therapeutic genome editing of an aberrant splice site in β-thalassemia by CRISPR/Cas9 with multiple sgRNAs.

Fei Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.